Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Ardisiacrispin A

SKU: orb1303350

Description

Ardisiacrispin A (Deglucocyclamin) is a cytotoxic agent with a GI(50) of 1.56 µM against HepG2 cells, inducing apoptosis and microtubule disassembly in Bel-7402 cells. The Ardisiacrispin (A+B) mixture also inhibits HL-60 cell proliferation by arresting the cell cycle at S phase and triggering apoptosis, highlighting its utility in anticancer research.

Research Area

Infectious Disease & Virology

Images & Validation

Key Properties

CAS Number23643-61-0
MW1061.21
Purity99.43% (May vary between batches)
FormulaC52H84O22
SMILES[H][C@@]12C[C@](C)(CC[C@@]11CO[C@@]22CC[C@]3([H])[C@@]4(C)CC[C@H](O[C@]5([H])OC[C@H](O[C@]6([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O[C@]6([H])OC[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H]5O[C@]5([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)(C)[C@]4([H])CC[C@@]3(C)[C@]2(C)C[C@H]1O)C=O
TargetHSV,Antibiotic
SolubilityDMSO:10.62 mg/mL (10.01 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (1.88 mM)

Bioactivity

In Vitro
Ardisiacrispin A+Ardisiacrispin B is a mixture of Ardisiacrispin A and ardisiacrispin B, derived from Ardisia crenata with a fixed proportion (2:1). METHODS AND RESULTS:The present study was conducted to investigate its anticancer activity on human cancer cells and its underlying mechanism of action. The (IC50)s of Ardisiacrispin A+Ardisiacrispin B on proliferation of several human cancer cell lines were in the range of 0.9-6.5 microg/ml by sulphorhodamine B-based colorimetric assay, in which Bel-7402 was the most sensitive cell line. Moreover, Ardisiacrispin A+Ardisiacrispin B induced dose-dependent apoptosis in Bel-7402 cells at doses of 1-10 microg/ml by flow cytometry, and resulted in the changes of the mitochondrial membrane depolarization, membrane permeability enhancement, and nuclear condensation in a dose-dependent manner through high-content screening analysis. Furthermore, Ardisiacrispin A+Ardisiacrispin B could disassemble microtubule in Bel-7402 cells; the fluorescence intensity of microtubules decreased at the concentration of 5-20 microg/ml. CONCLUSIONS: These findings suggest that Ardisiacrispin A+Ardisiacrispin B could inhibit the proliferation of Bel-7402 cells by inducing apoptosis and disassembling microtubule.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Deglucocyclamin, Ardisiacrispin A, LTS 4, LTS4, LTS-4, inhibit, Inhibitor, HSV, Saxifragifolin B

Similar Products

  • Ardisiacrispin B [orb1684758]

    112766-96-8

    1075.249

    C53H86O22

    5 mg
  • Ardisiacrispin A [orb1218344]

    >98% (HPLC)

    23643-61-0

    1061.22

    C52H84O22

    5 mg, 10 mg, 25 mg, 100 mg, 1 g, 500 mg, 200 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 80.00
5 mg
$ 140.00
10 mg
$ 180.00
1 ml x 10 mM (in DMSO)
$ 210.00
25 mg
$ 280.00
50 mg
$ 390.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry